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Letters to the Editor
OBuilt-in bias in HCV clearance in acute
o the Editor:
e read with interest the recent paper about hepatitis C virus
CV) clearance in patients with acute HCV infection [1]. We
re wondering why authors did not calculate risk ratio instead
f odds ratio (OR) when they have run a cohort study? They
an present how much is the incidence of HCV clearance and rel-
tive risk (RR) of factors affecting on such clearance, which is
ore precise than OR and real actual estimation of the strength
f risk factor. Reporting RR besides OR in univariate analysis
nd then multivariable OR based on logistic regression makes it
asy to interpret multivariable (adjusted) OR regarding ‘‘built-
-bias.’’ When the condition of interest has a high incidence
nd prospective data are available, like the study by Mangia
t al. [1], it is usually better to report the RR instead of OR. Imple-
enting OR as an estimate of the RR biases it in a direction oppo-
ite to the null hypothesis; that is, it tends to exaggerate the
agnitude of the association. This is called built-in bias which
negligible when the disease is relatively rare [2]. When the
cidence is high; like spontaneous HCV clearance and
on-responders to treatment in the present study, the bias can
e substantial [2]. In other words, built-in bias is responsible
r the discrepancy between the RR and OR estimates.
The value of this bias is equal to:
1 q
1 qþ
;
hen q+ is the incidence (probability) in exposed and q the inci-
ence in unexposed individuals. For instance, regarding response
treatment and IL28B, 31 out of 40 IL28B CC carriers vs. 27 out of
0 IL28B XT carriers were responder; in this way q+ and q would
e 77.5 and 67.5 percent respectively, indicating built in bias of
.4, which means OR overestimates RR estimation up to 1.4 fold.
egarding relationship between spontaneous HCV clearance and
undice or IL28B, built in bias is lower (about 1.3).
This shows that the value of bias may be considerable in this
tudy and similar researches and we should consider this issue
r future studies as a common mistake which is undertaken by
ost researchers.
Moreover, multivariate OR reported for HCV genotype and
28B (15.6 and 8.7, respectively) as predictors of SVR are not cor-
espondent to the results in the Table 3! Their value cannot be
inﬂuenced very much
such low number of s
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o the Editor:
e would like thank our colleagues for their insightful notes on
asic epidemiology. We agree with them that researchers and cli-
icians sometimes forget the different nature of the risk metrics.
Undoubtedly, odds ratios (OR) and relative risks (RR) have differ-
ent deﬁnitions and, therefore, different interpretations. The RR,
computed as the ratio of two risks, is a natural way to compare
risk proportions: a RR of 1.60 indicates a higher risk of 60% in
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